Vault-13

ACRIVON THERAPEUTICS INC ACRV

COMMON STOCK · Common Stock · CUSIP 004890109

19 institutional holders
14,965,63715.0m shares reported held*
71.7% of all shares outstanding*
$170.4mreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 20.9m as of 2022-12-09, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $11.38.

Biggest buyers

RA CAPITAL MANAGEMENT, L.P. New +4,810,508+4.8m
PERCEPTIVE ADVISORS LLC New +3,007,858+3.0m
Sands Capital Alternatives, LLC New +1,652,605+1.7m
CITADEL ADVISORS LLC New +1,634,104+1.6m
MARSHALL WACE, LLP New +1,223,252+1.2m
WELLINGTON MANAGEMENT GROUP LLP New +900,149+900.1k
NEA Management Company, LLC New +481,677+481.7k
HealthCor Management, L.P. New +284,201+284.2k
BANK OF MONTREAL /CAN/ New +42,444+42.4k
GOLDMAN SACHS GROUP INC New +38,800+38.8k

Biggest sellers

None

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
RA CAPITAL MANAGEMENT, L.P. 13D · may seek influence +7.2 pts · filed 2026-04-23 28.8% +7.2 pts 12.3m≈ $21.9m 2026-04-23
Sands Capital Life Sciences Pulse Fund II, L.P. 13G · passive investor -1.5 pts · filed 2026-08-13 5.3% -1.5 pts 2.3m≈ $4.1m 2026-08-13

Fell to 5% or below in the last year: CITADEL ADVISORS LLC (0.0%, 2026-05-15)

Insider purchases and sales in Q4 2022

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
101Q1 21: 0 buyingQ1 21: 0 sellingQ2 21: 0 buyingQ2 21: 0 sellingQ2 21Q3 21: 0 buyingQ3 21: 0 sellingQ4 21: 0 buyingQ4 21: 0 sellingQ4 21Q1 22: 0 buyingQ1 22: 0 sellingQ2 22: 0 buyingQ2 22: 0 sellingQ2 22Q3 22: 0 buyingQ3 22: 0 sellingQ4 22: 1 buyingQ4 22: 0 sellingQ4 22
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q1 20210—0——
Q2 20210—0——
Q3 20210—0——
Q4 20210—0——
Q1 20220—0——
Q2 20220—0——
Q3 20220—0——
Q4 20221$42.4m0——
DateInsiderTradeSharesPrice ValueTheir holding
2022-11-17 RA Capital Healthcare Fund LP +4 Director · See Footnotes Bought 3,389,500 $12.50 $42.4m3.4m shares +341%
2022-11-17 Chione Ltd +4 10% owner Bought 400,000 $12.50 $5.0m400.0k shares +12%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q4 2022

#ManagerLocationShares Value% of their portfolioChangeShares change
1 RA CAPITAL MANAGEMENT, L.P. 1.12% of their portfolio BOSTON, MA 4,810,5084.8m $55.4m $55.4m 1.12% New
2 PERCEPTIVE ADVISORS LLC 1.00% of their portfolio NEW YORK, NY 3,007,8583.0m $34.7m $34.7m 1.00% New
3 Sands Capital Alternatives, LLC 5.21% of their portfolio ARLINGTON, VA 1,652,6051.7m $19.0m $19.0m 5.21% New
4 CITADEL ADVISORS LLC 0.02% of their portfolio MIAMI, FL 1,634,1041.6m $18.2m $18.2m 0.02% New
5 MARSHALL WACE, LLP 0.04% of their portfolio LONDON, X0 1,223,2521.2m $14.1m $14.1m 0.04% New
6 WELLINGTON MANAGEMENT GROUP LLP 0.00% of their portfolio Boston, MA 900,149900.1k $10.0m $10.0m 0.00% New
7 FEDERATED HERMES, INC. 0.03% of their portfolio PITTSBURGH, PA 823,300823.3k $9.5m $9.5m 0.03% Not comparable
8 NEA Management Company, LLC 0.25% of their portfolio TIMONIUM, MD 481,677481.7k $4.4m $4.4m 0.25% New
9 HealthCor Management, L.P. 3.00% of their portfolio NEW YORK, NY 284,201284.2k $3.3m $3.3m 3.00% New
10 BANK OF MONTREAL /CAN/ 0.00% of their portfolio TORONTO, A6 42,44442.4k $545.0k $545.0k 0.00% New
11 GOLDMAN SACHS GROUP INC 0.00% of their portfolio NEW YORK, NY 38,80038.8k $447.0k $447.0k 0.00% New
12 TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio NEW YORK, NY 21,53421.5k $248.1k $248.1k 0.00% New
13 MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio NEW YORK, NY 19,63919.6k $226.0k $226.0k 0.00% New
14 DAFNA Capital Management LLC 0.05% of their portfolio LOS ANGELES, CA 15,64815.6k $180.3k $180.3k 0.05% New
15 UBS Group AG 0.00% of their portfolio ZURICH, V8 4,7484.7k $54.7k $54.7k 0.00% New
16 BARCLAYS PLC 0.00% of their portfolio LONDON, X0 4,1424.1k $47.7k $47.7k 0.00% First filing
17 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 869869 $10.0k $10.0k 0.00% New
18 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 159159 $2.0k $2.0k 0.00% New
19 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% New